• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and Japan Ophthalmol Drug Market Insights, Forecast to 2026

report cover
  • 3 September 2020
  • Healthcare
  • 131 Pages
  • Report Code: 24LS-21401
  • Formate :   
Download FREE Report Sample Download PDF File

Ophthalmol Drug -MARKET ADVISORY SERVICES

Ophthalmol Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Ophthalmol Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Ophthalmol Drug market is segmented into
Retinal disorders drugs
Allergic, inflammatory and infective drugs
Glaucoma drugs
Dry eye drugs

Segment by Application, the Ophthalmol Drug market is segmented into
Glaucoma
Dry eye syndrome
Retinal diseases
Other ophthalmic indications

Regional and Country-level Analysis
The Ophthalmol Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ophthalmol Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Ophthalmol Drug Market Share Analysis
Ophthalmol Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ophthalmol Drug business, the date to enter into the Ophthalmol Drug market, Ophthalmol Drug product introduction, recent developments, etc.
The major vendors covered:
Novartis
Allergan
Roche
Valeant
Regeneron
Santen
Bayer
Pfizer
Senju
Akorn
1 Study Coverage
1.1 Ophthalmol Drug Product Introduction
1.2 Market Segments
1.3 Key Ophthalmol Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ophthalmol Drug Market Size Growth Rate by Type
1.4.2 Retinal disorders drugs
1.4.3 Allergic, inflammatory and infective drugs
1.4.4 Glaucoma drugs
1.4.5 Dry eye drugs
1.5 Market by Application
1.5.1 Global Ophthalmol Drug Market Size Growth Rate by Application
1.5.2 Glaucoma
1.5.3 Dry eye syndrome
1.5.4 Retinal diseases
1.5.5 Other ophthalmic indications
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Ophthalmol Drug Market Size, Estimates and Forecasts
2.1.1 Global Ophthalmol Drug Revenue 2015-2026
2.1.2 Global Ophthalmol Drug Sales 2015-2026
2.2 Global Ophthalmol Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Ophthalmol Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Ophthalmol Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Ophthalmol Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Ophthalmol Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Ophthalmol Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Ophthalmol Drug Revenue Forecast by Region (2021-2026)

3 Global Ophthalmol Drug Competitor Landscape by Players
3.1 Global Top Ophthalmol Drug Sales by Manufacturers
3.1.1 Global Ophthalmol Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Ophthalmol Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Ophthalmol Drug Manufacturers by Revenue
3.2.1 Global Ophthalmol Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Ophthalmol Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ophthalmol Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ophthalmol Drug Revenue in 2019
3.2.5 Global Ophthalmol Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Ophthalmol Drug Price by Manufacturers
3.4 Global Ophthalmol Drug Manufacturing Base Distribution, Product Types
3.4.1 Ophthalmol Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ophthalmol Drug Product Type
3.4.3 Date of International Manufacturers Enter into Ophthalmol Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Ophthalmol Drug Market Size by Type (2015-2020)
4.1.1 Global Ophthalmol Drug Sales by Type (2015-2020)
4.1.2 Global Ophthalmol Drug Revenue by Type (2015-2020)
4.1.3 Ophthalmol Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ophthalmol Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Ophthalmol Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Ophthalmol Drug Revenue Forecast by Type (2021-2026)
4.2.3 Ophthalmol Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ophthalmol Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Ophthalmol Drug Market Size by Application (2015-2020)
5.1.1 Global Ophthalmol Drug Sales by Application (2015-2020)
5.1.2 Global Ophthalmol Drug Revenue by Application (2015-2020)
5.1.3 Ophthalmol Drug Price by Application (2015-2020)
5.2 Ophthalmol Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Ophthalmol Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Ophthalmol Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Ophthalmol Drug Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application
6.1 Japan Ophthalmol Drug Market Size YoY Growth 2015-2026
6.1.1 Japan Ophthalmol Drug Sales YoY Growth 2015-2026
6.1.2 Japan Ophthalmol Drug Revenue YoY Growth 2015-2026
6.1.3 Japan Ophthalmol Drug Market Share in Global Market 2015-2026
6.2 Japan Ophthalmol Drug Market Size by Players (International and Local Players)
6.2.1 Japan Top Ophthalmol Drug Players by Sales (2015-2020)
6.2.2 Japan Top Ophthalmol Drug Players by Revenue (2015-2020)
6.3 Japan Ophthalmol Drug Historic Market Review by Type (2015-2020)
6.3.1 Japan Ophthalmol Drug Sales Market Share by Type (2015-2020)
6.3.2 Japan Ophthalmol Drug Revenue Market Share by Type (2015-2020)
6.3.3 Japan Ophthalmol Drug Price by Type (2015-2020)
6.4 Japan Ophthalmol Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Ophthalmol Drug Sales Forecast by Type (2021-2026)
6.4.2 Japan Ophthalmol Drug Revenue Forecast by Type (2021-2026)
6.4.3 Japan Ophthalmol Drug Price Forecast by Type (2021-2026)
6.5 Japan Ophthalmol Drug Historic Market Review by Application (2015-2020)
6.5.1 Japan Ophthalmol Drug Sales Market Share by Application (2015-2020)
6.5.2 Japan Ophthalmol Drug Revenue Market Share by Application (2015-2020)
6.5.3 Japan Ophthalmol Drug Price by Application (2015-2020)
6.6 Japan Ophthalmol Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Ophthalmol Drug Sales Forecast by Application (2021-2026)
6.6.2 Japan Ophthalmol Drug Revenue Forecast by Application (2021-2026)
6.6.3 Japan Ophthalmol Drug Price Forecast by Application (2021-2026)

7 North America
7.1 North America Ophthalmol Drug Market Size YoY Growth 2015-2026
7.2 North America Ophthalmol Drug Market Facts & Figures by Country
7.2.1 North America Ophthalmol Drug Sales by Country (2015-2020)
7.2.2 North America Ophthalmol Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Ophthalmol Drug Market Size YoY Growth 2015-2026
8.2 Europe Ophthalmol Drug Market Facts & Figures by Country
8.2.1 Europe Ophthalmol Drug Sales by Country
8.2.2 Europe Ophthalmol Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Ophthalmol Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Ophthalmol Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Ophthalmol Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Ophthalmol Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Ophthalmol Drug Market Size YoY Growth 2015-2026
10.2 Latin America Ophthalmol Drug Market Facts & Figures by Country
10.2.1 Latin America Ophthalmol Drug Sales by Country
10.2.2 Latin America Ophthalmol Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Ophthalmol Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Ophthalmol Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Ophthalmol Drug Sales by Country
11.2.2 Middle East and Africa Ophthalmol Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Ophthalmol Drug Products Offered
12.1.5 Novartis Recent Development
12.2 Allergan
12.2.1 Allergan Corporation Information
12.2.2 Allergan Description and Business Overview
12.2.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Allergan Ophthalmol Drug Products Offered
12.2.5 Allergan Recent Development
12.3 Roche
12.3.1 Roche Corporation Information
12.3.2 Roche Description and Business Overview
12.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Roche Ophthalmol Drug Products Offered
12.3.5 Roche Recent Development
12.4 Valeant
12.4.1 Valeant Corporation Information
12.4.2 Valeant Description and Business Overview
12.4.3 Valeant Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Valeant Ophthalmol Drug Products Offered
12.4.5 Valeant Recent Development
12.5 Regeneron
12.5.1 Regeneron Corporation Information
12.5.2 Regeneron Description and Business Overview
12.5.3 Regeneron Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Regeneron Ophthalmol Drug Products Offered
12.5.5 Regeneron Recent Development
12.6 Santen
12.6.1 Santen Corporation Information
12.6.2 Santen Description and Business Overview
12.6.3 Santen Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Santen Ophthalmol Drug Products Offered
12.6.5 Santen Recent Development
12.7 Bayer
12.7.1 Bayer Corporation Information
12.7.2 Bayer Description and Business Overview
12.7.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bayer Ophthalmol Drug Products Offered
12.7.5 Bayer Recent Development
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Description and Business Overview
12.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Pfizer Ophthalmol Drug Products Offered
12.8.5 Pfizer Recent Development
12.9 Senju
12.9.1 Senju Corporation Information
12.9.2 Senju Description and Business Overview
12.9.3 Senju Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Senju Ophthalmol Drug Products Offered
12.9.5 Senju Recent Development
12.10 Akorn
12.10.1 Akorn Corporation Information
12.10.2 Akorn Description and Business Overview
12.10.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Akorn Ophthalmol Drug Products Offered
12.10.5 Akorn Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Novartis Ophthalmol Drug Products Offered
12.11.5 Novartis Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ophthalmol Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ophthalmol Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Ophthalmol Drug Market Segments

Table 2. Ranking of Global Top Ophthalmol Drug Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Ophthalmol Drug Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)

Table 4. Major Manufacturers of Retinal disorders drugs

Table 5. Major Manufacturers of Allergic, inflammatory and infective drugs

Table 6. Major Manufacturers of Glaucoma drugs

Table 7. Major Manufacturers of Dry eye drugs

Table 8. Global Ophthalmol Drug Market Size Growth Rate by Application 2020-2026 (K MT)

Table 9. Global Ophthalmol Drug Market Size by Region (K MT) & (US$ Million): 2020 VS 2026

Table 10. Global Ophthalmol Drug Sales by Regions 2015-2020 (K MT)

Table 11. Global Ophthalmol Drug Sales Market Share by Regions (2015-2020)

Table 12. Global Ophthalmol Drug Revenue by Regions 2015-2020 (US$ Million)

Table 13. Global Ophthalmol Drug Sales Forecast by Region (2021-2026) (K MT)

Table 14. Global Ophthalmol Drug Sales by Manufacturers (2015-2020) (K MT)

Table 15. Global Ophthalmol Drug Sales Share by Manufacturers (2015-2020)

Table 16. Global Ophthalmol Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 17. Global Ophthalmol Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmol Drug as of 2019)

Table 18. Ophthalmol Drug Revenue by Manufacturers (2015-2020) (US$ Million)

Table 19. Ophthalmol Drug Revenue Share by Manufacturers (2015-2020)

Table 20. Key Manufacturers Ophthalmol Drug Price (2015-2020) (USD/MT)

Table 21. Ophthalmol Drug Manufacturers Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers Ophthalmol Drug Product Type

Table 23. Date of International Manufacturers Enter into Ophthalmol Drug Market

Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 25. Global Ophthalmol Drug Sales by Type (2015-2020) (K MT)

Table 26. Global Ophthalmol Drug Sales Share by Type (2015-2020)

Table 27. Global Ophthalmol Drug Revenue by Type (2015-2020) (US$ Million)

Table 28. Global Ophthalmol Drug Revenue Share by Type (2015-2020)

Table 29. Ophthalmol Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT)

Table 30. Global Ophthalmol Drug Sales Share by Type (2021-2026)

Table 31. Global Ophthalmol Drug Sales by Application (2015-2020) (K MT)

Table 32. Global Ophthalmol Drug Sales Share by Application (2015-2020)

Table 33. Global Ophthalmol Drug Sales Share by Application (2021-2026)

Table 34. Global Ophthalmol Drug Sales Market Share Forecast by Application (2021-2026)

Table 35. Global Ophthalmol Drug Revenue by Application (2015-2020) (US$ Million)

Table 36. Global Ophthalmol Drug Revenue Market Share Forecast by Application (2021-2026)

Table 37. Japan Ophthalmol Drug Sales (K MT) of Key Companies (2015-2020)

Table 38. Japan Ophthalmol Drug Sales Share by Company (2015-2020)

Table 39. Japan Ophthalmol Drug Revenue (US$ Million) by Company (2015-2020)

Table 40. Japan Ophthalmol Drug Sales (K MT) by Type (2015-2020)

Table 41. Japan Ophthalmol Drug Sales Share by Type (2015-2020)

Table 42. Japan Ophthalmol Drug Revenue (US$ Million) Market Share by Type (2015-2020)

Table 43. Japan Ophthalmol Drug Price (K MT) by Type (2015-2020)

Table 44. Japan Ophthalmol Drug Sales (K MT) by Type (2021-2026)

Table 45. Japan Ophthalmol Drug Sales Share by Type (2021-2026)

Table 46. Japan Ophthalmol Drug Revenue (US$ Million) Market Share by Type (2021-2026)

Table 47. Japan Ophthalmol Drug Revenue Share by Type (2021-2026)

Table 48. Japan Ophthalmol Drug Price (K MT) by Type (2021-2026)

Table 49. Japan Ophthalmol Drug Sales (K MT) by Application (2015-2020)

Table 50. Japan Ophthalmol Drug Sales Share by Application (2015-2020)

Table 51. Japan Ophthalmol Drug Revenue (US$ Million) Market Share by Application (2015-2020)

Table 52. Japan Ophthalmol Drug Sales (K MT) by Application (2021-2026)

Table 53. Japan Ophthalmol Drug Sales Share by Application (2021-2026)

Table 54. Japan Ophthalmol Drug Revenue (US$ Million) Market Share by Application (2021-2026)

Table 55. Japan Ophthalmol Drug Revenue Share by Application (2021-2026)

Table 56. North America Ophthalmol Drug Sales by Country (2015-2020) (K MT)

Table 57. North America Ophthalmol Drug Sales Market Share by Country (2015-2020)

Table 58. North America Ophthalmol Drug Revenue by Country (2015-2020) (US$ Million)

Table 59. North America Ophthalmol Drug Revenue Market Share by Country (2015-2020)

Table 60. Europe Ophthalmol Drug Sales by Country (2015-2020) (K MT)

Table 61. Europe Ophthalmol Drug Sales Market Share by Country (2015-2020)

Table 62. Europe Ophthalmol Drug Revenue by Country (2015-2020) (US$ Million)

Table 63. Europe Ophthalmol Drug Revenue Market Share by Country (2015-2020)

Table 64. Asia Pacific Ophthalmol Drug Sales by Region (2015-2020) (K MT)

Table 65. Asia Pacific Ophthalmol Drug Sales Market Share by Region (2015-2020)

Table 66. Asia Pacific Ophthalmol Drug Revenue by Region (2015-2020) (US$ Million)

Table 67. Asia Pacific Ophthalmol Drug Revenue Market Share by Region (2015-2020)

Table 68. Latin America Ophthalmol Drug Sales by Country (2015-2020) (K MT)

Table 69. Latin America Ophthalmol Drug Sales Market Share by Country (2015-2020)

Table 70. Latin Americaa Ophthalmol Drug Revenue by Country (2015-2020) (US$ Million)

Table 71. Latin America Ophthalmol Drug Revenue Market Share by Country (2015-2020)

Table 72. Middle East and Africa Ophthalmol Drug Sales by Country (2015-2020) (K MT)

Table 73. Middle East and Africa Ophthalmol Drug Sales Market Share by Country (2015-2020)

Table 74. Middle East and Africa Ophthalmol Drug Revenue by Country (2015-2020) (US$ Million)

Table 75. Middle East and Africa Ophthalmol Drug Revenue Market Share by Country (2015-2020)

Table 76. Novartis Corporation Information

Table 77. Novartis Description and Business Overview

Table 78. Novartis Ophthalmol Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 79. Novartis Ophthalmol Drug Product

Table 80. Novartis Recent Development

Table 81. Allergan Corporation Information

Table 82. Allergan Description and Business Overview

Table 83. Allergan Ophthalmol Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 84. Allergan Product

Table 85. Allergan Recent Development

Table 86. Roche Corporation Information

Table 87. Roche Description and Business Overview

Table 88. Roche Ophthalmol Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 89. Roche Product

Table 90. Roche Recent Development

Table 91. Valeant Corporation Information

Table 92. Valeant Description and Business Overview

Table 93. Valeant Ophthalmol Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 94. Valeant Product

Table 95. Valeant Recent Development

Table 96. Regeneron Corporation Information

Table 97. Regeneron Description and Business Overview

Table 98. Regeneron Ophthalmol Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 99. Regeneron Product

Table 100. Regeneron Recent Development

Table 101. Santen Corporation Information

Table 102. Santen Description and Business Overview

Table 103. Santen Ophthalmol Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 104. Santen Product

Table 105. Santen Recent Development

Table 106. Bayer Corporation Information

Table 107. Bayer Description and Business Overview

Table 108. Bayer Ophthalmol Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 109. Bayer Product

Table 110. Bayer Recent Development

Table 111. Pfizer Corporation Information

Table 112. Pfizer Description and Business Overview

Table 113. Pfizer Ophthalmol Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 114. Pfizer Product

Table 115. Pfizer Recent Development

Table 116. Senju Corporation Information

Table 117. Senju Description and Business Overview

Table 118. Senju Ophthalmol Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 119. Senju Product

Table 120. Senju Recent Development

Table 121. Akorn Corporation Information

Table 122. Akorn Description and Business Overview

Table 123. Akorn Ophthalmol Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 124. Akorn Product

Table 125. Akorn Recent Development

Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 127. Key Challenges

Table 128. Market Risks

Table 129. Main Points Interviewed from Key Ophthalmol Drug Players

Table 130. Ophthalmol Drug Customers List

Table 131. Ophthalmol Drug Distributors List

Table 132. Research Programs/Design for This Report

Table 133. Key Data Information from Secondary Sources

Table 134. Key Data Information from Primary Sources

List of Figures

Figure 1. Ophthalmol Drug Product Picture

Figure 2. Global Ophthalmol Drug Sales Market Share by Type in 2020 & 2026

Figure 3. Retinal disorders drugs Product Picture

Figure 4. Allergic, inflammatory and infective drugs Product Picture

Figure 5. Glaucoma drugs Product Picture

Figure 6. Dry eye drugs Product Picture

Figure 7. Global Ophthalmol Drug Sales Market Share by Application in 2020 & 2026

Figure 8. Glaucoma

Figure 9. Dry eye syndrome

Figure 10. Retinal diseases

Figure 11. Other ophthalmic indications

Figure 12. Ophthalmol Drug Report Years Considered

Figure 13. Global Ophthalmol Drug Market Size 2015-2026 (US$ Million)

Figure 14. Global Ophthalmol Drug Sales 2015-2026 (K MT)

Figure 15. Global Ophthalmol Drug Market Size Market Share by Region: 2020 Versus 2026

Figure 16. Global Ophthalmol Drug Sales Market Share by Region (2015-2020)

Figure 17. Global Ophthalmol Drug Sales Market Share by Region in 2019

Figure 18. Global Ophthalmol Drug Revenue Market Share by Region (2015-2020)

Figure 19. Global Ophthalmol Drug Revenue Market Share by Region in 2019

Figure 20. Global Ophthalmol Drug Sales Share by Manufacturer in 2019

Figure 21. The Top 10 and 5 Players Market Share by Ophthalmol Drug Revenue in 2019

Figure 22. Ophthalmol Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 23. Global Ophthalmol Drug Sales Market Share by Type (2015-2020)

Figure 24. Global Ophthalmol Drug Sales Market Share by Type in 2019

Figure 25. Global Ophthalmol Drug Revenue Market Share by Type (2015-2020)

Figure 26. Global Ophthalmol Drug Revenue Market Share by Type in 2019

Figure 27. Global Ophthalmol Drug Market Share by Price Range (2015-2020)

Figure 28. Global Ophthalmol Drug Sales Market Share by Application (2015-2020)

Figure 29. Global Ophthalmol Drug Sales Market Share by Application in 2019

Figure 30. Global Ophthalmol Drug Revenue Market Share by Application (2015-2020)

Figure 31. Global Ophthalmol Drug Revenue Market Share by Application in 2019

Figure 32. Japan Ophthalmol Drug Sales Growth Rate 2015-2026 (K MT)

Figure 33. Japan Ophthalmol Drug Revenue Growth Rate 2015-2026 (US$ Million)

Figure 34. Japan Ophthalmol Drug Market Share in Global Market 2015-2026

Figure 35. Japan 5 and 10 Largest Ophthalmol Drug Players Market Share by Revenue in Ophthalmol Drug in 2019

Figure 36. Japan Ophthalmol Drug Revenue Share by Type (2015-2020)

Figure 37. Japan Ophthalmol Drug Revenue Growth Rate by Type in 2015 & 2019

Figure 38. Japan Ophthalmol Drug Revenue Share by Application (2015-2020)

Figure 39. Japan Ophthalmol Drug Revenue Growth Rate by Application in 2015 & 2019

Figure 40. North America Ophthalmol Drug Sales Growth Rate 2015-2020 (K MT)

Figure 41. North America Ophthalmol Drug Revenue Growth Rate 2015-2020 (US$ Million)

Figure 42. North America Ophthalmol Drug Sales Market Share by Country in 2019

Figure 43. North America Ophthalmol Drug Revenue Market Share by Country in 2019

Figure 44. U.S. Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 45. U.S. Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 46. Canada Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 47. Canada Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 48. Europe Ophthalmol Drug Sales Growth Rate 2015-2020 (K MT)

Figure 49. Europe Ophthalmol Drug Revenue Growth Rate 2015-2020 (US$ Million)

Figure 50. Europe Ophthalmol Drug Sales Market Share by Country in 2019

Figure 51. Europe Ophthalmol Drug Revenue Market Share by Country in 2019

Figure 52. Germany Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 53. Germany Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 54. France Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 55. France Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 56. U.K. Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 57. U.K. Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 58. Italy Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 59. Italy Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 60. Russia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 61. Russia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 62. Asia Pacific Ophthalmol Drug Sales Growth Rate 2015-2020 (K MT)

Figure 63. Asia Pacific Ophthalmol Drug Revenue Growth Rate 2015-2020 (US$ Million)

Figure 64. Asia Pacific Ophthalmol Drug Sales Market Share by Region in 2019

Figure 65. Asia Pacific Ophthalmol Drug Revenue Market Share by Region in 2019

Figure 66. China Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 67. China Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 68. Japan Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 69. Japan Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. South Korea Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 71. South Korea Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 72. India Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 73. India Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. Australia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 75. Australia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. Taiwan Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 77. Taiwan Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Indonesia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 79. Indonesia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 80. Thailand Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 81. Thailand Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 82. Malaysia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 83. Malaysia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 84. Philippines Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 85. Philippines Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 86. Vietnam Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 87. Vietnam Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 88. Latin America Ophthalmol Drug Sales Growth Rate 2015-2020 (K MT)

Figure 89. Latin America Ophthalmol Drug Revenue Growth Rate 2015-2020 (US$ Million)

Figure 90. Latin America Ophthalmol Drug Sales Market Share by Country in 2019

Figure 91. Latin America Ophthalmol Drug Revenue Market Share by Country in 2019

Figure 92. Mexico Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 93. Mexico Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 94. Brazil Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 95. Brazil Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 96. Argentina Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 97. Argentina Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 98. Middle East and Africa Ophthalmol Drug Sales Growth Rate 2015-2020 (K MT)

Figure 99. Middle East and Africa Ophthalmol Drug Revenue Growth Rate 2015-2020 (US$ Million)

Figure 100. Middle East and Africa Ophthalmol Drug Sales Market Share by Country in 2019

Figure 101. Middle East and Africa Ophthalmol Drug Revenue Market Share by Country in 2019

Figure 102. Turkey Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 103. Turkey Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 104. Saudi Arabia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 105. Saudi Arabia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 106. U.A.E Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)

Figure 107. U.A.E Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 108. Porter's Five Forces Analysis

Figure 109. Ophthalmol Drug Value Chain

Figure 110. Channels of Distribution

Figure 111. Distributors Profiles

Figure 112. Bottom-up and Top-down Approaches for This Report

Figure 113. Data Triangulation

Figure 114. Key Executives Interviewed

Novartis

Allergan

Roche

Valeant

Regeneron

Santen

Bayer

Pfizer

Senju

Akorn

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3120

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase